Expression of selenoprotein genes is affected by obesity of pigs fed a high-fat diet

Journal of Nutrition

Volumn 145, Issue 7, 2015, Pages 1394-1401

  Zhao, Hua ^a   Li, Ke ^a   Tang, Jia Yong ^a   Zhou, Ji Chang ^b   Wang, Kang Ning ^a   Xia, Xin Jie ^a,c   Lei, Xin Gen ^a,d  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

^b Shen Zhen Center for Chronic Disease Control   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

High fat diet; Inflammation; Obesity; Pig; Selenoprotein gene

Indexed keywords

ADIPONECTIN; AGOUTI PROTEIN; CYTOKINE; GLUTATHIONE PEROXIDASE 3; INTERLEUKIN 6; IODOTHYRONINE DEIODINASE 1; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; RESISTIN; SELENOPROTEIN; SELENOPROTEIN W; SELENOPROTEIN W 1; SELH PROTEIN; SELI PROTEIN; SELK PROTEIN; SELM PROTEIN; SELO PROTEIN; SELS PROTEIN; SELX PROTEIN; SEP15 PROTEIN; SEPP1 PROTEIN; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; THIOREDOXIN REDUCTASE 2; THIOREDOXIN REDUCTASE 3; THYROID HORMONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL PIG; GENE EXPRESSION; HYPOTHALAMUS; KIDNEY; LIPID DIET; LIVER; MUSCLE; NONHUMAN; OBESITY; PANCREAS; PERIRENAL FAT; SUBCUTANEOUS FAT; THYROID GLAND; TRIACYLGLYCEROL BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; BLOOD; DISEASE MODEL; GENETICS; INFLAMMATION; METABOLISM; PIG; UPREGULATION;

AGOUTI; MAMMALIA; SUIDAE; SUS; ZEA MAYS;

ADIPONECTIN; AGOUTI SIGNALING PROTEIN; ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DOWN-REGULATION; INFLAMMATION; INTERLEUKIN-6; LEPTIN; OBESITY; RECEPTORS, LEPTIN; RESISTIN; RNA, MESSENGER; SELENOPROTEINS; SWINE; THYROID HORMONES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84935502771     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.211318     Document Type: Article

References (68)

1. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-6.
2. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012;307:491-7.
3. Drewnowski A, Specter SE. Poverty and obesity: the role of energy density and energy costs. Am J Clin Nutr 2004;79:6-16.
4. Birse RT, Choi J, Reardon K, Rodriguez J, Graham S, Diop S, Ocorr K, Bodmer R, Oldham S. High-fat-diet-induced obesity and heart dysfunction are regulated by the TOR pathway in Drosophila. Cell Metab 2010;12:533-44.
5. Spurlock ME, Gabler NK. The development of porcine models of obesity and the metabolic syndrome. J Nutr 2008;138:397-402.
6. Patterson JK, Yasuda K, Welch RM, Miller DD, Lei XG. Supplemental dietary inulin of variable chain lengths alters intestinal bacterial populations in young pigs. J Nutr 2010;140:2158-61.
7. Li K, Zhao H, Zhou JC, Tang JY, Lei XG, Wang KN. Differentially expressed genes in subcutaneous tissues in an obese pig models induced by a high-fat diets. J Anim Vet Adv 2011;10:1804-10.
8. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003;112:1785-8.
9. Manning PJ, Sutherland WH, McGrath MM, de Jong SA, Walker RJ, Williams MJ. Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity (Silver Spring) 2008;16:2046-52.
10. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010;314:1-16.
11. McClung JP, Roneker CA, Mu W, Lisk DJ, Langlais P, Liu F, Lei XG. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc Natl Acad Sci USA 2004;101: 8852-7.
12. Pepper MP, Vatamaniuk MZ, Yan X, Roneker CA, Lei XG. Impacts of dietary selenium deficiency on metabolic phenotypes of dietrestricted GPX1-overexpressing mice. Antioxid Redox Signal 2011; 14:383-90.
13. Zeng MS, Li X, Liu Y, Zhao H, Zhou JC, Li K, Huang JQ, Sun LH, Tang JY, Xia XJ, et al. A high-selenium diet induces insulin resistance in gestating rats and their offspring. Free Radic Biol Med 2012;52: 1335-42.
14. Liu Y, Zhao H, Zhang Q, Tang J, Li K, Xia XJ, Wang KN, Lei XG. Prolonged dietary selenium deficiency or excess does not globally affect selenoprotein gene expression and/or protein production in various tissues of pigs. J Nutr 2012;142:1410-6.
15. Yan X, Pepper MP, Vatamaniuk MZ, Roneker CA, Li L, Lei XG. Dietary selenium deficiency partially rescues type 2 diabetes-like phenotypes of glutathione peroxidase-1-overexpressing male mice. J Nutr 2012;142:1975-82.
16. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN. Characterization of mammalian selenoproteomes. Science 2003;300:1439-43.
17. Zhou JC, Zhao H, Li JG, Xia XJ, Wang KN, Zhang YJ, Liu Y, Zhao Y, Lei XG. Selenoprotein gene expression in thyroid and pituitary of young pigs is not affected by dietary selenium deficiency or excess. J Nutr 2009;139:1061-6.
18. Zhou J, Huang K, Lei XG. Selenium and diabetes-evidence from animal studies. Free Radic Biol Med 2013;65:1548-56.
19. Wang XD, Vatamaniuk MZ, Wang SK, Roneker CA, Simmons RA, Lei XG. Molecular mechanisms for hyperinsulinaemia induced by overproduction of selenium-dependent glutathione peroxidase-1 in mice. Diabetologia 2008;51:1515-24.
20. Chen X, Scholl TO, Leskiw MJ, Donaldson MR, Stein TP. Association of glutathione peroxidase activity with insulin resistance and dietary fat intake during normal pregnancy. J Clin Endocrinol Metab 2003;88:5963-8.
21. Walder K, Kantham L, McMillan JS, Trevaskis J, Kerr L, De Silva A, Sunderland T, Godde N, Gao Y, Bishara N, et al. Tanis: a link between type 2 diabetes and inflammation? Diabetes 2002;51:1859-66.
22. Shchedrina VA, Zhang Y, Labunskyy VM, Hatfield DL, Gladyshev VN. Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Antioxid Redox Signal 2010;12:839-49.
23. Gao Y, Feng HC, Walder K, Bolton K, Sunderland T, Bishara N, Quick M, Kantham L, Collier GR. Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress-SelS is a novel glucose-regulated protein. FEBS Lett 2004;563:185-90.
24. Gao Y, Hannan NR, Wanyonyi S, Konstantopolous N, Pagnon J, Feng HC, Jowett JB, Kim KH, Walder K, Collier GR. Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine 2006;33:246-51.
25. Gao Y, Pagnon J, Feng HC, Konstantopolous N, Jowett JB, Walder K, Collier GR. Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells. Biochem Biophys Res Commun 2007;356: 636-41.
26. Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, Wang J, Abel Azim DM, Cai G, Mahaney MC, Comuzzie AG, et al. Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 2005; 37:1234-41.
27. Müller AS, Most E, Pallauf J. Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic dbdb mice. J Anim Physiol Anim Nutr (Berl) 2005;89:94-104.
28. Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 2011;96:E1325-9.
29. Kaur P, Rizk NM, Ibrahim S, Younes N, Uppal A, Dennis K, Karve T, Blakeslee K, Kwagyan J, Zirie M, et al. iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes. J Proteome Res 2012;11:5527-39.
30. Choi HY, Hwang SY, Lee CH, Hong HC, Yang SJ, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, et al. Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic fatty liver disease. Diabetes Metab J 2013;37:63-71.
31. Huang JQ, Li DL, Zhao H, Sun LH, Xia XJ, Wang KN, Luo X, Lei XG. The selenium deficiency disease exudative diathesis in chicks is associated with downregulation of seven common selenoprotein genes in liver and muscle. J Nutr 2011;141:1605-10.
32. Wang H, Storlien LH, Huang XF. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Am J Physiol Endocrinol Metab 2002;282:E1352-9.
33. Masuo K, Straznicky NE, Lambert GW, Katsuya T, Sugimoto K, Rakugi H, Socratous F, Hastings J, Lambert EA, Ogihara T, et al. Leptinreceptor polymorphisms relate to obesity through blunted leptinmediated sympathetic nerve activation in a Caucasian male population. Hypertens Res 2008;31:1093-100.
34. Hariri N, Thibault L. High-fat diet-induced obesity in animal models. Nutr Res Rev 2010;23:270-99.
35. Horton TJ, Drougas H, Brachey A, Reed GW, Peters JC, Hill JO. Fat and carbohydrate overfeeding in humans: different effects on energy storage. Am J Clin Nutr 1995;62:19-29.
36. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007;56:1010-3.
37. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, Shai I, Kloting N, Stumvoll M, Bashan N, et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007;92:2240-7.
38. Catli G, Anik A, Tuhan Hü , Kume T, Bober E, Abaci A. The relation of leptin and soluble leptin receptor levels with metabolic and clinical parameters in obese and healthy children. Peptides 2014;56:72-6.
39. Lou PH, Yang G, Huang L, Cui Y, Pourbahrami T, Radda GK, Li C, Han WP. Reduced body weight and increased energy expenditure in transgenic mice over-expressing soluble leptin receptor. PLoS One 2010;5:e11669.
40. Huang L, Wang ZW, Li C. Modulation of circulating leptin levels by its soluble receptor. J Biol Chem 2001;276:6343-9.
41. Klebanova EM. The influence hypocaloric diet on induces of carbohydrate metabolism and concentration of leptin and soluble leptin receptor in the blood serum of the type 2 diabetic patients. Vopr Pitan 2006;75:29-31.
42. Kratzsch J, Deimel A, Galler A, Kapellen T, Klinghammer A, Kiess W. Increased serum soluble leptin receptor levels in children and adolescents with type 1 diabetes mellitus. Eur J Endocrinol 2004;151:475-81.
43. Conrad M, Schneider M, Seiler A, Bornkamm GW. Physiological role of phospholipid hydroperoxide glutathione peroxidase in mammals. Biol Chem 2007;388:1019-25.
44. Dabkowski ER, Williamson CL, Hollander JM. Mitochondria-specific transgenic overexpression of phospholipid hydroperoxide glutathione peroxidase (GPx4) attenuates ischemia/reperfusion-associated cardiac dysfunction. Free Radic Biol Med 2008;45:855-65.
45. Brigelius-Flohé R. Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 2006;387:1329-35.
46. Horibata Y, Hirabayashi Y. Identification and characterization of human ethanolaminephosphotransferase1. J Lipid Res 2007;48:503-8.
47. Han SJ, Lee BC, Yim SH, Gladyshev VN, Lee SR. Characterization of mammalian selenoprotein o: a redox-active mitochondrial protein. PLoS One 2014;9:e95518.
48. Ye Y, Shibata Y, Yun C, Ron D, Rapoport TA. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 2004;429:841-7.
49. Lobanov AV, Hatfield DL, Gladyshev VN. Eukaryotic selenoproteins and selenoproteomes. Biochim Biophys Acta 2009;1790:1424-8.
50. Schomburg L, Kohrle J. On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol Nutr Food Res 2008;52:1235-46.
51. Marsili A, Zavacki AM, Harney JW, Larsen PR. Physiological role and regulation of iodothyronine deiodinases: a 2011 update. J Endocrinol Invest 2011;34:395-407.
52. Williams GR, Bassett JH. Deiodinases: the balance of thyroid hormone: local control of thyroid hormone action: role of type 2 deiodinase. J Endocrinol 2011;209:261-72.
53. Roman M, Jitaru P, Barbante C. Selenium biochemistry and its role for human health. Metallomics 2014;6:25-54.
54. Chandra R, Liddle RA. Modulation of pancreatic exocrine and endocrine secretion. Curr Opin Gastroenterol 2013;29:517-22.
55. Shchedrina VA, Everley RA, Zhang Y, Gygi SP, Hatfield DL, Gladyshev VN. Selenoprotein K binds multiprotein complexes and is involved in the regulation of endoplasmic reticulum homeostasis. J Biol Chem 2011;286:42937-48.
56. Lei XG, Cheng WH. New roles for an old selenoenzyme: evidence from glutathione peroxidase-1 null and overexpressing mice. J Nutr 2005; 135:2295-8.
57. Lei XG, Cheng WH, McClung JP. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr 2007;27:41-61.
58. Sunde RA, Raines AM. Selenium regulation of the selenoprotein and nonselenoprotein transcriptomes in rodents. Adv Nutr 2011;2:138-50.
59. Sunde RA, Raines AM, Barnes KM, Evenson JK. Selenium status highly regulates selenoprotein mRNA levels for only a subset of the selenoproteins in the selenoproteome. Biosci Rep 2009;29:329-38.
60. O'Rahilly S, Farooqi IS, Yeo GS, Challis BG. Minireview: human obesity-lessons from monogenic disorders. Endocrinology 2003;144: 3757-64.
61. Swarbrick MM, Vaisse C. Emerging trends in the search for genetic variants predisposing to human obesity. Curr Opin Clin Nutr Metab Care 2003;6:369-75.
62. Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL. Overexpression of Agrt leads to obesity in transgenic mice. Nat Genet 1997;17:273-4.
63. Sharma K, McCue P, Dunn SR. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 2003;284:F1138-44.
64. Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, Cao Q, Atsumi G, Malone H, Krishnan B, et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 2005;1:107-19.
65. Díez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293-300.
66. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423:762-9.
67. Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acidbinding protein aP2. Nature 2007;447:959-65.
68. Yang R, Castriota G, Chen Y, Cleary MA, Ellsworth K, Shin MK, Tran JL, Vogt TF, Wu M, Xu S, et al. RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice. Int J Obes (Lond) 2011;35:217-25.